Suchergebnisse - "Immunologic Factors"

PubPharm (30.340)

41

Immunological factors linked to geographical variation in vaccine responses

enthalten in: Nature reviews. Immunology | 2024

von van Dorst, M. | Pyuza, J. | Nkurunungi, G. | +8

42

Trx4, a novel thioredoxin protein, is important for Toxoplasma gondii fitness

enthalten in: Parasites & vectors | 2024

von Zhang, Z. | Wang, M. | Sun, L. | +7

43

Emerging polymeric materials for treatment of oral diseases : design strategy towards a unique oral environment

enthalten in: Chemical Society reviews | 2024

von Jia, B. | Zhang, B. | Li, J. | +8

44

Legionella Pneumonia in a Patient on a Tumor Necrosis Factor-Alpha Inhibitor

enthalten in: The American journal of medicine | 2024

von Kovacik, R. | Szymanski, K. | Doroshow, J. | +1

45

Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma

enthalten in: Environmental toxicology | 2024

von Lin, J. | Chen, Y. | Zhang, Z. | +2

46

Effect of Plasmapheresis on the Efficacy of Rituximab in Antibody-Mediated Rejection Patients

enthalten in: Transplantation proceedings | 2024

von Lee, J. | Lee, H. | Kim, K. | +3

47

Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient

enthalten in: Journal of neurology | 2024

von Cutillo, G. | Rubin, M. | d'Amore, G. | +6

48

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab : a real-life study

enthalten in: Journal of neurology | 2024

von Scherer, L. | Soudant, M. | Pittion-Vouyovitch, S. | +4

49

Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis : A real world study

enthalten in: Clinical neurology and neurosurgery | 2024

von Alroughani, R. | Al-Hashel, J. | Ahmed, S.

50

Soluble immune-checkpoint factors : a potential immunotherapy biomarker

enthalten in: The Journal of clinical investigation | 2024

von Tan, A. | Cook, S. | Khasraw, M.